1. Home
  2. NGNE vs RCKY Comparison

NGNE vs RCKY Comparison

Compare NGNE & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$27.00

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Logo Rocky Brands Inc.

RCKY

Rocky Brands Inc.

HOLD

Current Price

$43.49

Market Cap

318.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGNE
RCKY
Founded
2003
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
327.8M
318.6M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
NGNE
RCKY
Price
$27.00
$43.49
Analyst Decision
Strong Buy
Buy
Analyst Count
7
1
Target Price
$63.57
$40.00
AVG Volume (30 Days)
138.7K
42.5K
Earning Date
05-08-2026
04-28-2026
Dividend Yield
N/A
1.43%
EPS Growth
0.93
94.74
EPS
N/A
2.96
Revenue
N/A
$270,408,000.00
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$4.90
P/E Ratio
N/A
$14.62
Revenue Growth
N/A
N/A
52 Week Low
$11.78
$13.05
52 Week High
$37.27
$48.70

Technical Indicators

Market Signals
Indicator
NGNE
RCKY
Relative Strength Index (RSI) 64.63 60.56
Support Level $19.40 $28.57
Resistance Level $29.05 $44.83
Average True Range (ATR) 1.86 1.50
MACD 0.53 0.13
Stochastic Oscillator 78.73 78.01

Price Performance

Historical Comparison
NGNE
RCKY

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About RCKY Rocky Brands Inc.

Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.

Share on Social Networks: